Approved
Wegovy® Pen
Semaglutide — the proven once-weekly GLP-1 injection.
- FDA-approved GLP-1 injection with semaglutide
- Avg. 35 lbs lost in one year in clinical trials¹
- Range of dosages from 0.25 mg–7.2 mg
- A once-weekly GLP-1 injection for weight management.
- Helps reduce hunger and slows how quickly food moves through the stomach.
- Promotes long-term weight loss with lifestyle changes and continued treatment.²
- Contains semaglutide — a clinically-proven ingredient that's also in Ozempic®.*
- Semaglutide mimics a naturally-occurring hormone in the body (GLP-1) released after eating to signal fullness.
- Helps regulate appetite and blood sugar, and slows digestion to keep you feeling full longer.
The proven weekly injection.
Get started todayOn average, people on the Wegovy pen lose 25% of their weight in a year.
*Based on clinical trial data. Individual results vary.
See your potential
How much could you lose?
Current weight
252lbs
You could lose
38lbs
Based on clinical GLP-1 trial averages. Individual results vary.
How it works
The science, simplified.
Once-weekly subcutaneous semaglutide steadily curbs appetite and cravings while improving glycemic control — clinically proven for long-term weight loss.
Disclaimer: Dosage, treatment plan, and pricing will vary based on your individual health profile and the recommendations of your licensed provider. Final pricing and protocol are determined after clinical review. This page is for informational purposes only and is not a substitute for medical advice. See Important Safety Information.